Literature DB >> 17963856

Reducing publication bias of prospective clinical trials through trial registration.

Lisa N Abaid1, David A Grimes, Kenneth F Schulz.   

Abstract

Publication bias is the selective publishing of favorable or statistically significant results. This practice, over time, distorts the medical literature by depicting inordinately optimistic outcomes for treatments and interventions. Sources of publication bias include preferential publishing by journals and preferential submission by researchers. Mandatory trial registration, as instituted by the International Committe of Medical Journal Editors (ICMJE), should reduce publication bias by improving the ability to identify all trials pertaining to a specific intervention. Contraception endorses the views of the ICMJE and will now require registration of all prospective trials.

Mesh:

Year:  2007        PMID: 17963856     DOI: 10.1016/j.contraception.2007.06.013

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

1.  Registering a clinical trial.

Authors:  Maria Augusta T Bortolini
Journal:  Int Urogynecol J       Date:  2017-04-27       Impact factor: 2.894

2.  Result publication of Chinese trials in World Health Organization primary registries.

Authors:  Xuemei Liu; Youping Li; Senlin Yin; Shangqi Song
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

3.  Legislation for trial registration and data transparency.

Authors:  Zhao-Xiang Bian; Tai-Xiang Wu
Journal:  Trials       Date:  2010-05-26       Impact factor: 2.279

4.  Comparison of published orthopaedic trauma trials following registration in Clinicaltrials.gov.

Authors:  Rajiv Gandhi; Meryam Jan; Holly N Smith; Nizar N Mahomed; Mohit Bhandari
Journal:  BMC Musculoskelet Disord       Date:  2011-12-07       Impact factor: 2.362

Review 5.  Barriers to and facilitators of interventions to counter publication bias: thematic analysis of scholarly articles and stakeholder interviews.

Authors:  Christina Kien; Barbara Nußbaumer; Kylie J Thaler; Ursula Griebler; Megan G Van Noord; Petra Wagner; Gerald Gartlehner
Journal:  BMC Health Serv Res       Date:  2014-11-13       Impact factor: 2.655

6.  Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.

Authors:  Constance X Zou; Jessica E Becker; Adam T Phillips; James M Garritano; Harlan M Krumholz; Jennifer E Miller; Joseph S Ross
Journal:  Trials       Date:  2018-10-23       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.